Literature DB >> 8380248

Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.

T Nagao1, P M Vanhoutte.   

Abstract

The endothelial cells inhibit the tone of the underlying vascular smooth muscle by releasing endothelium-derived relaxing factors (EDRF). The existence of at least two such factors, nitric oxide and endothelium-derived hyperpolarizing factor (EDHF), has been demonstrated. EDHF is an as yet unidentified substance that hyperpolarizes vascular smooth muscle cells and causes their relaxation. The contribution of endothelium-dependent hyperpolarization varies along the vascular tree. Particularly in smaller blood vessels, EDHF acts on vascular smooth muscle in cooperation with nitric oxide. Basal release of EDHF is not likely to occur, at least in vitro. The production and/or release of EDHF is regulated by the cytosolic concentration of Ca2+ ions, derived both from the extracellular space and intracellular stores. Calmodulin may be involved in its production and/or release. EDHF hyperpolarizes the vascular smooth muscle by opening K+ channels. The hyperpolarization closes voltage-dependent Ca2+ channels and, as a consequence, EDHF relaxes blood vessels. In the absence of chemical identification of EDHF, it is difficult to assess its contribution to endothelium-dependent relaxations in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380248     DOI: 10.1165/ajrcmb/8.1.1

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

1.  Bradykinin attenuates the [Ca(2+)](i) response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHF.

Authors:  J Marchetti; F Praddaude; R Rajerison; J L Ader; F Alhenc-Gelas
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits.

Authors:  K Noguchi; S Yamashiro; T Matsuzaki; M Sakanashi; J Nakasone; K Miyagi; M Sakanashi
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

3.  Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels.

Authors:  H Dong; Y Jiang; W C Cole; C R Triggle
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Inhibition of endothelium-dependent vascular relaxation by lysophosphatidylcholine: impact of lysophosphatidylcholine on mechanisms involving endothelium-derived nitric oxide and endothelium derived hyperpolarizing factor.

Authors:  D E Froese; J McMaster; R Y Man; P C Choy; E A Kroeger
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

5.  NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels.

Authors:  X J Yuan; M L Tod; L J Rubin; M P Blaustein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.

Authors:  G R Drummond; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  ATP-induced vasodilation in human skeletal muscle.

Authors:  E E M van Ginneken; P Meijer; N Verkaik; P Smits; G A Rongen
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

8.  Substance P-induced relaxation and hyperpolarization in human cerebral arteries.

Authors:  J Petersson; P M Zygmunt; L Brandt; E D Högestätt
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery.

Authors:  P M Zygmunt; E D Högestätt
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

10.  Influence of regular exercise training on post-exercise hemodynamic regulation to orthostatic challenge.

Authors:  Jun Sugawara; Hidehiko Komine; Taiki Miyazawa; Tomoko Imai; Shigehiko Ogoh
Journal:  Front Physiol       Date:  2014-06-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.